Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
B
|
Boilermech Holdings Bhd
KLSE:BOILERM
|
MY |
|
S
|
SIK Cheong Bhd
KLSE:SCB
|
MY |
|
S
|
Shopify Inc
LSE:0VHA
|
CA |
|
H
|
Human Creation Holdings Inc
TSE:7361
|
JP |
|
nLIGHT Inc
NASDAQ:LASR
|
US |
|
H
|
Haypp Group AB (publ)
STO:HAYPP
|
SE |
|
Hempacco Co Inc
OTC:HPCO
|
US |
|
Bank of The Ryukyus Ltd
TSE:8399
|
JP |
|
Blue Prism Group PLC
LSE:PRSM
|
UK |
|
P
|
Platina Resources Ltd
ASX:PGM
|
AU |
|
Caesarstone Ltd
NASDAQ:CSTE
|
IL |
|
Fagerhult AB
STO:FAG
|
SE |
|
Jones Lang LaSalle Inc
NYSE:JLL
|
US |
|
Fine-Line Circuits Ltd
BSE:517264
|
IN |
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
M
|
Maruyama MFG Co Inc
TSE:6316
|
JP |
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
NO |
|
Phoenix Biotech Acquisition Corp
NASDAQ:CERO
|
US |
|
Smartsheet Inc
NYSE:SMAR
|
US |
|
B
|
Baria Thermal Power JSC
VN:BTP
|
VN |
|
Tata Steel Ltd
NSE:TATASTEEL
|
IN |
Bankruptcy Probability
Mink Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mink Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
50.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mink Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mink Therapeutics Inc has total debt of 5.7m USD. This includes both short-term (5.7m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
